{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T05:16:33Z","timestamp":1695791793640},"reference-count":27,"publisher":"Wiley","issue":"s3","license":[{"start":{"date-parts":[[2005,9,6]],"date-time":"2005-09-06T00:00:00Z","timestamp":1125964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:p>Patients with vascular dementia (VaD) and Alzheimer's disease with cerebrovascular disease (AD\u2003+\u2003CVD) have dementia associated with underlying CVD. Although diagnosis of VaD is challenging, VaD is typically characterized by a stepwise progression of dementia that is closely associated with stroke and focal neurological findings, and a symptom profile that often includes executive dysfunction leading to decreased ability to perform instrumental activities of daily living (IADL). In contrast, AD\u2003+\u2003CVD patients typically present with progressive deterioration of cognition\/memory that may also be influenced by concurrent cerebrovascular events. Early diagnosis and intervention are desirable to prevent further decline due to subsequent vascular events. Management of CVD can limit deterioration of cognitive symptoms in VaD patients, and treatment benefits with cholinesterase inhibitors may be realized as improvement above baseline levels in dementia symptoms. Results from a combined analysis of two 24\u2010week, placebo\u2010controlled clinical trials show that donepezil\u2010treated VaD patients improve in cognition, global function, and performance of IADL. In contrast, AD\u2003+\u2003CVD patients may continue to decline despite management of CVD, and treatment benefits should be recognized as initial improvements followed by stabilization or slowed decline of dementia symptoms over time. In post\u2010marketing studies, donepezil\u2010treated AD and AD\u2003+\u2003CVD patients show similar benefits in cognition, global function, and quality of life. The results of these studies support the use of donepezil in treatment of patients with VaD or AD\u2003+\u2003CVD.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2005.01323.x","type":"journal-article","created":{"date-parts":[[2005,9,6]],"date-time":"2005-09-06T15:41:16Z","timestamp":1126021276000},"page":"17-21","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Dementia with cerebrovascular disease: the benefits of early treatment"],"prefix":"10.1111","volume":"12","author":[{"given":"R. J.","family":"Schindler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,9,6]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7046051"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000091396.95360.E1"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1997.00550180021007"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000017126"},{"issue":"2","key":"e_1_2_9_6_1","first-page":"256","article-title":"Donepezil provides significant benefits on cognition, global function, and activities of daily living in patients with vascular dementia [abstract]","volume":"15","author":"Farcnik K","year":"2003","journal-title":"Int Psychogeriatr"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_2_9_8_1","volume-title":"Presented at the American Association for Geriatric Psychiatry's 17th Annual Meeting","author":"Fr\u00f6lich L","year":"2004"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199912003-00017"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.7.939"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1998.tb06015.x"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(77)90073-9"},{"key":"e_1_2_9_13_1","volume-title":"Presented at the American Association for Geriatric Psychiatry's 17th Annual Meeting","author":"Pratt RD","year":"2004"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.1.136"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(02)00008-1"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.5155.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.2.250"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.11.1356"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1999.tb126889.x"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)91561-T"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-5_Part_2-200309021-00014"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/jscd.2003.5"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01271206"},{"issue":"4","key":"e_1_2_9_24_1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1017\/S0317167100037252","article-title":"Muscarinic binding and choline acetyltransferase in postmortem brains of demented patients","volume":"13","author":"Waller SB","year":"1986","journal-title":"Can J Neurol Sci"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1989.tb03807.x"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000078943.50032.FC"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)00830-3"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(01)01855-9"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2005.01323.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2005.01323.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T21:52:06Z","timestamp":1695765126000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2005.01323.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,6]]},"references-count":27,"journal-issue":{"issue":"s3","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1468-1331.2005.01323.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2005.01323.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,6]]},"assertion":[{"value":"2005-09-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}